Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer

被引:59
|
作者
Porta, M
Malats, N
Guarner, L
Carrato, A
Rifà, J
Salas, A
Corominas, JM
Andreu, M
Real, FX
机构
[1] Univ Autonoma Barcelona, Inst Municipal Invest Med, E-08003 Barcelona, Spain
[2] Hosp Gen Valle Hebron, Dept Gastroenterol, Barcelona, Spain
[3] Hosp Gen Elche, Dept Oncol, Alicante, Spain
[4] Hosp Son Dureta, Dept Oncol, Mallorca, Spain
[5] Hosp Mutua Terrassa, Dept Pathol, Barcelona, Spain
[6] Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08003 Barcelona, Spain
[7] Univ Autonoma Barcelona, Hosp Mar, Dept Gastroenterol, E-08003 Barcelona, Spain
关键词
D O I
10.1136/jech.53.11.702
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Study objective-To analyse the relation between coffee consumption and mutations in the K-ras gene in exocrine pancreatic cancer. Design-Case-case study. Consumption of coffee among cases with the activating mutation in the K-ras gene was compared with that of cases without the mutation. Setting and patients-All cases of pancreatic cancer newly diagnosed at five hospitals in Spain during three years were included in the PANKRAS II Study (n=185, of whom 121 whose tissue was available for molecular analysis are the object of the present report). Over 88% were personally interviewed in hospital. DNA was amplified from paraffin wax embedded tissues, and mutations in codon 12 of K-ras were detected by the artificial RFLP technique. Main results-Mutations were found in tumours from 94 of 121 patients (77.7%). Mutations were more common among regular coffee drinkers than among nonregular coffee drinkers (82.0% v 55.6%, p=0.018, n=107). The odds ratio adjusted by age, sex, smoking and alcohol drinking was 5.41 (95% CI 1.64, 17.78). The weekly intake of coffee was significantly higher among patients with a mutated tumour (mean of 14.5 cups/week v 8.8 among patients with a wild type tumour, p<0.05). With respect to non-regular coffee drinkers, the odds ratio of a mutated tumour adjusted by age, sex, smoking and alcohol drinking was 3.26 for drinkers of 2-7 cups/week, 5.77 for drinkers of 8-14 cups/week and 9.99 for drinkers of greater than or equal to 15 cups/week (p<0.01, test for trend). Conclusions-Pancreatic cancer cases without activating mutations in the K-ras gene had drank significantly less coffee than cases with a mutation, with a significant dose response relation: the less they drank, the less likely their tumours were to harbour a mutation. In exocrine pancreatic cancer the K-ras gene may be activated less often among non-regular coffee drinkers than among regular drinkers. Caffeine, other coffee compounds or other factors with which coffee drinking is associated may modulate K-ras activation.
引用
收藏
页码:702 / 709
页数:8
相关论文
共 50 条
  • [31] Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis
    Lian-yuan Tao
    Ling-fu Zhang
    Dian-rong Xiu
    Chun-hui Yuan
    Zhao-lai Ma
    Bin Jiang
    World Journal of Surgical Oncology, 14
  • [32] Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis
    Tao, Lian-yuan
    Zhang, Ling-fu
    Xiu, Dian-rong
    Yuan, Chun-hui
    Ma, Zhao-lai
    Jiang, Bin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [33] Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas
    Fukushima, H
    Yamamoto, H
    Itoh, F
    Nakamura, H
    Min, YF
    Horiuchi, S
    Iku, S
    Sasaki, S
    Imai, K
    CARCINOGENESIS, 2001, 22 (07) : 1049 - 1052
  • [34] IDENTIFICATION OF K-RAS MUTATIONS IN PANCREATIC-JUICE IN THE EARLY DIAGNOSIS OF PANCREATIC-CANCER
    BERTHELEMY, P
    BOUISSON, M
    ESCOURROU, J
    VAYSSE, N
    RUMEAU, JL
    PRADAYROL, L
    ANNALS OF INTERNAL MEDICINE, 1995, 123 (03) : 188 - 191
  • [35] K-ras Mutations and Cetuximab in Colorectal Cancer
    Albitar, Maher
    Yeh, Chenhsiung
    Ma, Wanlong
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (08): : 834 - 834
  • [36] Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice:: Comparison with:: K-ras mutations
    Uehara, H
    Nakaizumi, A
    Tatsuta, M
    Baba, M
    Takenaka, A
    Uedo, N
    Sakai, N
    Yano, H
    Iishi, H
    Ohigashi, H
    Ishikawa, O
    Okada, S
    Kakizoe, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09): : 2513 - 2518
  • [37] K-ras mutations at codon 12 in pancreatic duct lesions associated with pancreatic cancer.
    Luettges, J
    Schlehe, B
    Menke, M
    Vogel, I
    Kremer, B
    Kloeppel, G
    MODERN PATHOLOGY, 1998, 11 (01) : 154A - 154A
  • [38] Targeting K-Ras signaling in pancreatic cancer
    Barbacid, Mariano
    CANCER RESEARCH, 2015, 75
  • [39] Associations between K-ras mutation, smoking, and prognosis of pancreatic cancer
    Saito, Kei
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Takahara, Naminatsu
    Hamada, Tsuyoshi
    Miyabayashi, Koji
    Yamamoto, Keisuke
    Mizuno, Suguru
    Mohri, Dai
    Kogure, Hirofumi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [40] Association between cigarette smoking and K-ras mutations in colorectal adenomas.
    Martínez, ME
    Matzman, T
    Marshall, JR
    Einspahr, J
    Reid, M
    Guillén-Rodríguez, J
    van Leeuwen, B
    Ahnen, DJ
    Alberts, DS
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (11) : S69 - S69